289 related articles for article (PubMed ID: 8771367)
1. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect.
Nagai T; Urata M; Yamada H
Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367
[TBL] [Abstract][Full Text] [Related]
2. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice.
Nagai T; Yamada H
Immunopharmacol Immunotoxicol; 1998 May; 20(2):267-81. PubMed ID: 9653672
[TBL] [Abstract][Full Text] [Related]
3. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system.
Yamada H; Nagai T
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):185-92. PubMed ID: 9646280
[TBL] [Abstract][Full Text] [Related]
4. In vivo anti-influenza virus activity of kampo (Japanese herbal) medicine "sho-seiryu-to" and its mode of action.
Nagai T; Yamada H
Int J Immunopharmacol; 1994 Aug; 16(8):605-13. PubMed ID: 7527377
[TBL] [Abstract][Full Text] [Related]
5. Effects of Clinacanthus siamensis leaf extract on influenza virus infection.
Wirotesangthong M; Nagai T; Yamada H; Amnuoypol S; Mungmee C
Microbiol Immunol; 2009 Feb; 53(2):66-74. PubMed ID: 19291089
[TBL] [Abstract][Full Text] [Related]
6. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model.
Nagai T; Arai Y; Emori M; Nunome SY; Yabe T; Takeda T; Yamada H
Int Immunopharmacol; 2004 Oct; 4(10-11):1353-65. PubMed ID: 15313433
[TBL] [Abstract][Full Text] [Related]
7. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
[TBL] [Abstract][Full Text] [Related]
8. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
[TBL] [Abstract][Full Text] [Related]
9. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.
Asahi-Ozaki Y; Yoshikawa T; Iwakura Y; Suzuki Y; Tamura S; Kurata T; Sata T
J Med Virol; 2004 Oct; 74(2):328-35. PubMed ID: 15332283
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
12. Effects of TheraMax on influenza virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
[TBL] [Abstract][Full Text] [Related]
13. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
[TBL] [Abstract][Full Text] [Related]
14. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
15. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
[TBL] [Abstract][Full Text] [Related]
16. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
17. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
Reeth KV; Brown I; Essen S; Pensaert M
Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
[TBL] [Abstract][Full Text] [Related]
18. [Effect of anti-influenza virus H3N2 of Hypericum japonicum in vivo].
Liu N; Hu XL; Meng YR; Zhu YT; Huang BS; Lin PZ
Zhong Yao Cai; 2008 Jul; 31(7):1022-4. PubMed ID: 18973021
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses.
Li F; Wang QJ; Zhu BL; Wang M
Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):709-14. PubMed ID: 10678103
[TBL] [Abstract][Full Text] [Related]
20. Anti-influenza-virus activity of total alkaloids from Commelina communis L.
Bing FH; Liu J; Li Z; Zhang GB; Liao YF; Li J; Dong CY
Arch Virol; 2009; 154(11):1837-40. PubMed ID: 19774337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
